Risk of post-lung transplant renal dysfunction in adults with cystic fibrosis

Chest

Volumn 142, Issue 1, 2012, Pages 185-191

  Quon, Bradley S ^a,b   Mayer Hamblett, Nicole ^c   Aitken, Moira L ^a   Goss, Christopher H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; INSULIN TREATMENT; KIDNEY DYSFUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTTRANSPLANT RENAL DYSFUNCTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE;

EID: 84863799902     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1926     Document Type: Article

References (25)

1. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report - 2010. J Heart Lung Transplant. 2010;29(10):1104-1118.
2. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant. 2005;24(8):956-967. (Pubitemid 41127175)
3. Hadjiliadis D. Special considerations for patients with cystic fibrosis undergoing lung transplantation. Chest. 2007;131(4):1224-1231. (Pubitemid 46608728)
4. Pattison JM, Petersen J, Kuo P, Valantine V, Robbins RC, Theodore J. The incidence of renal failure in one hundred consecutive heart-lung transplant recipients. Am J Kidney Dis. 1995;26(4):643-648.
5. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neuberger JM. Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation. 1998;66(1):59-66. (Pubitemid 28341169)
6. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol. 1999;10(5):1136-1144. (Pubitemid 29203102)
7. Bloom RD, Reese PP. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol. 2007;18(12):3031-3041. (Pubitemid 350223963)
8. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349(10):931-940. (Pubitemid 37064766)
9. Barraclough K, Menahem SA, Bailey M, Thomson NM. Predictors of decline in renal function after lung transplantation. J Heart Lung Transplant. 2006;25(12):1431-1435. (Pubitemid 44909471)
10. Meachery G, De Soyza A, Nicholson A, et al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax. 2008;63(8):725-731.
11. Ishani A, Erturk S, Hertz MI, Matas AJ, Savik K, Rosenberg ME. Predictors of renal function following lung or heart-lung transplantation. Kidney Int. 2002;61(6):2228-2234. (Pubitemid 34539340)
12. Canales M, Youssef P, Spong R, et al. Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation. Am J Transplant. 2006;6(9):2157-2163. (Pubitemid 44199550)
13. Chandrakantan A, de Mattos AM, Naftel D, Crosswy A, Kirklin J, Curtis JJ. Increasing referral for renal transplant evaluation in recipients of nonrenal solid-organ transplants: a single-center experience. Clin J Am Soc Nephrol. 2006;1(4): 832-836.
14. Fustik S, Pop-Jordanova N, Slaveska N, Koceva S, Efremov G. Metabolic alkalosis with hypoelectrolytemia in infants with cystic fibrosis. Pediatr Int. 2002;44(3):289-292. (Pubitemid 34827729)
15. Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol. 2005;39(1):15-20. (Pubitemid 39628598)
16. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2009 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation;2010.
17. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098.
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
19. 2002 National Kidney Foundation clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. National Kidney Foundation website. http://www.kidney.org/professionals/KDOQI/guidelines-ckd/p4- class-g1.htm. Accessed September 14, 2011.
20. Cantarovich D, Renou M, Megnigbeto A, et al. Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events. Transplantation. 2005;79(1):72-78. (Pubitemid 40140003)
21. Lucey MR, Abdelmalek MF, Gagliardi R, et al. A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant. 2005;5(5):1111-1119. (Pubitemid 40571262)
22. Quon BS, Mayer-Hamblett N, Aitken ML, Smyth AR, Goss CH. Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med. 2011;184(10): 1147-1152.
23. Fernandes I, Zhang Y, Qi Y, et al. Impact of reduced nephron mass on cyclosporine- and/or sirolimus-induced nephrotoxicity. Transplantation. 2009;88(12):1323-1331.
24. Luyckx VA, Brenner BM. The clinical importance of nephron mass. J Am Soc Nephrol. 2010;21(6):898-910.
25. Myers GL, Miller WG, Coresh J, et alNational Kidney Disease Education Program Laboratory Working Group. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006;52(1):5-18. (Pubitemid 43032461)